Cormorant Asset Management, LP
50 holdingsFiling period: 2026-06-30Current AUM: $1.40Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines I | 640.0K | $214.3M | $184.7M | 13.18% | -245,500 | 2026-06-30 |
| 2 | BBOT | Bridgebio Oncology Therapeut | 17.88M | $136.2M | $48.3M | 3.45% | -- | 2026-06-30 |
| 3 | PBLS | Parabilis Medicines Inc | 4.62M | $126.3M | $132.5M | 9.45% | -- | 2026-06-30 |
| 4 | RAPP | Rapport Therapeutics Inc | 2.66M | $110.7M | $64.3M | 4.59% | -300,000 | 2026-06-30 |
| 5 | ERAS | Erasca Inc | 6.00M | $109.9M | $89.9M | 6.41% | +200.0K | 2026-06-30 |
| 6 | EWTX | Edgewise Therapeutics Inc | 2.51M | $102.0M | $97.7M | 6.97% | -750,000 | 2026-06-30 |
| 7 | EYPT | Eyepoint Inc | 7.00M | $100.1M | $2.7M | 0.19% | -1,265,000 | 2026-06-30 |
| 8 | ALMS | Alumis Inc | 3.29M | $92.5M | $22.6M | 1.62% | -663,645 | 2026-06-30 |
| 9 | ABVX | Abivax SA | 675.0K | $90.0M | $60.1M | 4.29% | -85,000 | 2026-06-30 |
| 10 | DNTH | Dianthus Therapeutics Inc | 750.0K | $73.1M | $62.0M | 4.43% | -200,000 | 2026-06-30 |
| 11 | DRUG | Bright Minds Biosciences Inc | 900.0K | $63.2M | $51.0M | 3.64% | -159,331 | 2026-06-30 |
| 12 | MLTX | Moonlake Immunotherapeutics | 3.21M | $62.4M | $40.3M | 2.88% | -1,275,000 | 2026-06-30 |
| 13 | BIOA | Bioage Labs Inc | 2.39M | $58.6M | $14.2M | 1.01% | -500,000 | 2026-06-30 |
| 14 | ORKA | Oruka Therapeutics Inc | 533.3K | $50.8M | $51.5M | 3.68% | -- | 2026-06-30 |
| 15 | ANL | Adlai Nortye Ltd | 3.98M | $45.7M | $40.9M | 2.92% | +1.08M | 2026-06-30 |
| 16 | BBIO | Bridgebio Pharma Inc | 550.0K | $41.0M | $38.9M | 2.78% | -300,000 | 2026-06-30 |
| 17 | TNGX | Tango Therapeutics Inc | 1.30M | $40.6M | $29.3M | 2.09% | -125,000 | 2026-06-30 |
| 18 | — | Biohaven Ltd | 2.61M | $38.8M | $38.8M | 2.77% | +850.0K | 2026-06-30 |
| 19 | AGMB | Agomab Therapeutics NV | 2.47M | $32.0M | $19.6M | 1.40% | -- | 2026-06-30 |
| 20 | MBX | Mbx Biosciences Inc | 550.0K | $30.4M | $30.0M | 2.14% | -570,000 | 2026-06-30 |
| 21 | CLYM | Climb Bio Inc | 2.11M | $27.5M | $21.8M | 1.55% | -- | 2026-06-30 |
| 22 | OLMA | Olema Pharmaceuticals Inc | 2.15M | $26.9M | $15.8M | 1.12% | -2,250,000 | 2026-06-30 |
| 23 | DMRA | Damora Therapeutics Inc | 1.00M | $26.0M | $22.0M | 1.57% | -525,000 | 2026-06-30 |
| 24 | — | Pharvaris N V | 750.0K | $25.9M | $25.9M | 1.85% | -250,000 | 2026-06-30 |
| 25 | CRBP | Corbus Pharmaceuticals Hldgs | 2.34M | $22.0M | $9.9M | 0.71% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2